Show simple item record

dc.contributor.authorDimaras, H
dc.contributor.authorCorson, TW
dc.date.accessioned2018-01-12T07:18:33Z
dc.date.available2018-01-12T07:18:33Z
dc.date.issued2018-01
dc.identifier.citationDimaras, Helen, and Timothy W. Corson. "Retinoblastoma, the visible CNS tumor: A review." Journal of Neuroscience Research.en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/29314142
dc.identifier.urihttp://hdl.handle.net/11295/102340
dc.description.abstractThe pediatric ocular cancer retinoblastoma is the only central nervous system (CNS) tumor readily observed without specialized equipment: it can be seen by, and in, the naked eye. This accessibility enables unique imaging modalities. Here, we review this cancer for a neuroscience audience, highlighting these clinical and research imaging options, including fundus imaging, optical coherence tomography, ultrasound, and magnetic resonance imaging. We also discuss the subtype of retinoblastoma driven by the MYCN oncogene more commonly associated with neuroblastoma, and consider trilateral retinoblastoma, in which an intracranial tumor arises along with ocular tumors in patients with germline RB1 gene mutations. Retinoblastoma research and clinical care can offer insights applicable to CNS malignancies, and also benefit from approaches developed elsewhere in the CNS.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectMYCN; cancer genetics; neuroimaging; optical coherence tomography; pediatric cancer; pineoblastomaen_US
dc.titleRetinoblastoma, the visible CNS tumor: A review.en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States